Akamatsu, K., Matsunaga, K., Sugiura, H., Koarai, A., Hirano, T., Minakata, Y., & Ichinose, M. (2011). Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker? Frontiers Research Foundation.
Chicago-stil citatAkamatsu, Keiichiro, Kazuto Matsunaga, Hisatoshi Sugiura, Akira Koarai, Tsunahiko Hirano, Yoshiaki Minakata, och Masakazu Ichinose. Improvement of Airflow Limitation By Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What Is the Specific Marker? Frontiers Research Foundation, 2011.
MLA-referensAkamatsu, Keiichiro, et al. Improvement of Airflow Limitation By Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What Is the Specific Marker? Frontiers Research Foundation, 2011.